Items where authors include "Burns, JE"

Article

Pettitt, GA, Hurst, CD, Khan, Z et al. (7 more authors) (2023) Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro. Journal of Pathology, 259 (2). pp. 220-232. ISSN 0022-3417

Hurst, CD, Cheng, G, Platt, FM et al. (7 more authors) (2022) Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling. The Journal of Pathology: Clinical Research, 8 (3). pp. 279-293. ISSN 2056-4538

Turner, LD, Trinh, CH orcid.org/0000-0002-5087-5011, Hubball, RA et al. (5 more authors) (2022) From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor. Journal of Medicinal Chemistry, 65 (2). pp. 1481-1504. ISSN 0022-2623

Hurst, CD, Cheng, G, Platt, FM et al. (16 more authors) (2021) Stage-stratified molecular profiling of non-muscle-invasive bladder cancer provides improved biological, clinical and therapeutic insights. Cell Reports Medicine, 2 (12). 100472. ISSN 2666-3791

Burns, JE, Hurst, CD, Knowles, MA orcid.org/0000-0002-9363-8657 et al. (2 more authors) (2021) The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets. Cancer Science. cas.15047. ISSN 1347-9032

Hurst, CD orcid.org/0000-0001-7719-1325, Alder, O orcid.org/0000-0002-7975-9727, Platt, FM et al. (15 more authors) (2017) Genomic Subtypes of Non-Invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency. Cancer Cell, 32 (5). pp. 701-715. ISSN 1535-6108